Superstable homogeneous iodinated formulation technology: revolutionizing transcatheter arterial chemoembolization-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Superstable homogeneous iodinated formulation technology: revolutionizing transcatheter arterial chemoembolization

Published:2020-10 Issue:20 Volume:65 Page:1685-1687
ISSN:2095-9273
Container-title:Science Bulletin
language:en
Short-container-title:Science Bulletin

Author:

Cheng Hongwei,Yang Xiaoming,Liu Gang

Funder

Major State Basic Research Development Program of China

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Program for New Century Excellent Talents in University

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference14 articles.

1. Epidemiology of hepatocellular carcinoma in the asia-pacific region;Zhu;Gut Liver,2016

2. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients;Sato;J Gastroenterol,2012

3. A superstable homogeneous lipiodol-icg formulation for locoregional hepatocellular carcinoma treatment;Chen;J Control Release,2020

4. Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals–a comprehensive review;Padrela;Adv Drug Deliv Rev,2018

5. In vivo drug delivery performance of lipiodol-based emulsion or drug-eluting beads in patients with hepatocellular carcinoma;Lilienberg;Mol Pharmaceut,2017

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic and pH dual responsive injectable magnetic zeolitic imidazole framework based colloidal gel for interventional treatment on hepatocellular carcinoma;Chemical Engineering Journal;2024-10

2. Supercritical Fluids: An Innovative Strategy for Drug Development;Bioengineering;2024-08-04

3. Cerenkov radiation shining a light for cancer theranostics;Nano Today;2024-04

4. Two-dimensional material–based nanomedicines for cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024

5. Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery;Frontiers in Oncology;2023-12-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3